Molecular pharmacology of the opioid/nociceptin system

Current Anaesthesia and Critical Care

Volumn 13, Issue 6, 2002, Pages 305-312

  Johnson, E E ^a   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dynorphins; Enkephalins; Nociceptin; Opioid; Receptor

Indexed keywords

ANALGESIC AGENT; CALCIUM CHANNEL; CALCIUM ION; CODEINE; CYCLIC AMP; CYPRODIME; DELTA OPIATE RECEPTOR; DEXTROPROPOXYPHENE; DYNORPHIN; ENDORPHIN; ENKEPHALIN; FENTANYL; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; KETAZOCINE; LIGAND; METHADONE; MORPHINE; MU OPIATE RECEPTOR; N ALLYLNORMETAZOCINE; NALOXONE; NALTREXONE; NALTRINDOLE; NOCICEPTIN; OPIATE; OPIATE RECEPTOR; PENTAZOCINE; PETHIDINE; POTASSIUM ION; SUFENTANIL; UNINDEXED DRUG;

ANALGESIA; CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; DRUG TARGETING; HUMAN; MOLECULAR MECHANICS; OPIATE ADDICTION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SPINAL ANESTHESIA; SUBSTANCE ABUSE;

EID: 0036959688     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1054/cacc.2003.0426     Document Type: Review

References (28)

1. Dhawan B N, Cesselin F, Raghubir R, et al. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996; 48(4): 567-592.
2. Calo G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor a novel therapeutic target. Br J Pharmacol 2000; 129(7): 1261-1283.
3. Mogil J S, Pasternak G W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 2001; 53(3): 381-415.
4. Cox B M, Chavkin C, Christie M J, et al. Opioid receptors. In: Girdlestone D (ed). The IUPHAR Compendium of Receptor Characterization and Classification. London: IUPHAR Media Ltd, 2000; 321-333.
5. Jordan B A, Devi L A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399(6737): 697-700.
6. Xie G X, Meuser T, Pietruck C, Sharma M, Palmer P. Presence of opioid receptor-like (ORLI) receptor mRNA splice variants in peripheral sensory and sympathetic neuronal ganglia. Life Sci 1999; 64(22): 2029-2037.
7. Pan Y X, Xu J, Mahurter L, Bolan E, Xu M, Pasternak G W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci USA 2001; 98(24): 14 084-14 089.
8. 375 residues within the carboxyl tail differentially regulates [micro]-opioid receptor internalization. J Biol Chem 2001; 276(16): 12 774-12 780.
9. Hawes B E, Graziano M P, Lambert D G. Cellular actions of nociceptin: transduction mechanisms. Peptides 2000; 21(7): 961-967.
10. Schlicker E, Morari M. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides 2000; 21(7): 1023-1029.
11. Wei L N, Loh H H. Regulation of opioid receptor expression. Curr Opin Pharmacol 2002; 2(1): 69-75.
12. Harrison C, Lambert D G. Opioid Pharmacology. In: Gullo A (ed). Anaesthesia, Pain and Intensive Care Medicine: Berlin: Springer, 2000; 387-394.
13. Henderson G, McKnight A T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin F Q. Trends Pharmacol Sci 1997; 18(8): 293-300.
14. Meunier J C. Nociceptin/orphanin FQ and the opioid receptor-like ORLI receptor. Eur J Pharmacol 1997; 340(1): 1-15.
15. Mollereau C, Simons M J, Soularue P, et al. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 1996; 93(16): 8666-8670.
16. Kummer W, Fischer A. Nociceptin and its receptor in guinea-pig sympathetic ganglia. Neurosci Lett 1997; 234(1): 35-38.
17. Kieffer B L, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 2002; 66(5): 285-306.
18. Houtani T, Nishi M, Takeshima H, et al. Distribution of nociceptin/ orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice. J Comp Neurol 2000; 424(3): 489-508.
19. Okuda-Ashitaka E, Ito S. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor. Peptides 2000; 21(7): 1101-1109.
20. 10]orphanin FQ/nociceptin(1-11) binding sites in rat brain. J Comp Neurol 2000; 423(2): 319-329.
21. 2, a new selective nociceptin receptor antagonist. Br J Pharmacol 2000; 129(6): 1183-1193.
22. 2, a novel potent and selective antagonist of the nociceptin/ orphanin FQ receptor. Br J Pharmacol 2002; 136(2): 303-311.
23. Dautzenberg F M, Wichmann J Higelin J et al. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORLI receptor in vitro and lack of tolerance in vivo. J Pharmacol Exp Ther 2001; 298(2): 812-819.
24. 2, a novel specific radioligand for the nociceptin/orphanin FQ receptor. Naunyn Schmiedebergs Arch Pharmacol 2000; 362(6): 538-545.
25. Kawamoto H, Ozaki S, Itoh Y et al. Discovery of the first potent and selective small molecule opioid receptor-like (ORLI) antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J Med Chem 1999; 42(25): 5061-5063.
26. Bigoni R, Calo G, Rizzi A et al. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol 2000; 361(5): 565-568.
27. Yamada H, Nakamoto H, Suzuki Y, Ito T and Aisaka K. Pharmacological profiles of a novel opioid receptor-like 1 (ORLI) receptor antagonist, JTC-801. Br J Pharmacol 2002; 135(2): 323-332.
28. Becker J A, Wallace A, Garzon A et al. Ligands for kappa-opioid and ORLI receptors identified from a conformationally constrained peptide combinatorial library. J Biol Chem 1999; 274(39): 27 513-27 522.